2B-Alert App 2.0: personalized caffeine recommendations for optimal alertness.
Sleep
; 46(7)2023 07 11.
Article
em En
| MEDLINE
| ID: mdl-36987747
ABSTRACT
STUDY OBJECTIVES:
If properly consumed, caffeine can safely and effectively mitigate the effects of sleep loss on alertness. However, there are no tools to determine the amount and time to consume caffeine to maximize its effectiveness. Here, we extended the capabilities of the 2B-Alert app, a unique smartphone application that learns an individual's trait-like response to sleep loss, to provide personalized caffeine recommendations to optimize alertness.METHODS:
We prospectively validated 2B-Alert's capabilities in a 62-hour total sleep deprivation study in which 21 participants used the app to measure their alertness throughout the study via the psychomotor vigilance test (PVT). Using PVT data collected during the first 36 hours of the sleep challenge, the app learned the participant's sleep-loss response and provided personalized caffeine recommendations so that each participant would sustain alertness at a pre-specified target level (mean response time of 270 milliseconds) during a 6-hour period starting at 44 hours of wakefulness, using the least amount of caffeine possible. Starting at 42 hours, participants consumed 0 to 800 mg of caffeine, per the app recommendation.RESULTS:
2B-Alert recommended no caffeine to five participants, 100-400 mg to 11 participants, and 500-800 mg to five participants. Regardless of the consumed amount, participants sustained the target alertness level ~80% of the time.CONCLUSIONS:
2B-Alert automatically learns an individual's phenotype and provides personalized caffeine recommendations in real time so that individuals achieve a desired alertness level regardless of their sleep-loss susceptibility.Palavras-chave
Texto completo:
1
Coleções:
01-internacional
Base de dados:
MEDLINE
Assunto principal:
Cafeína
/
Aplicativos Móveis
Tipo de estudo:
Prognostic_studies
Limite:
Humans
Idioma:
En
Revista:
Sleep
Ano de publicação:
2023
Tipo de documento:
Article
País de afiliação:
Estados Unidos